Edward M. Md Kaye Cytokinetics Inc (CYTK) insider trading activity

Edward M. Md Kaye is Director of CYTOKINETICS INC. Currently has a direct ownership of 23,230 shares of CYTK, which is worth approximately $820,715. The most recent transaction as insider was on Jul 07, 2021, when has been sold 63 shares (Common Stock) at a price of $19.77 per share, resulting in proceeds of $1,246. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 23.2K

30.23% 3M change

7.62% 12M change

Total Value Held $820,715

Edward M. MD Kaye Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jul 07 2021	BUY Grant, award, or other acquisition	$1,246 $19.77 p/Share	63 Added 0.97%	6,459 Common Stock
Jul 01 2021	BUY Grant, award, or other acquisition	$9,986 $20.98 p/Share	476 Added 6.93%	6,396 Common Stock
May 12 2021	BUY Grant, award, or other acquisition	-	5,000 Added 45.79%	5,920 Common Stock
Apr 01 2021	BUY Grant, award, or other acquisition	$9,996 $24.44 p/Share	409 Added 30.78%	920 Common Stock
Jan 04 2021	BUY Grant, award, or other acquisition	$9,995 $19.56 p/Share	511 Added 50.0%	511 Common Stock
Oct 05 2020	SELL Open market or private sale	$600,000 $30.0 p/Share	20,000 Reduced 100.0%	0 Common Stock
Oct 05 2020	BUY Exercise of conversion of derivative security	$152,200 $7.61 p/Share	20,000 Added 50.0%	20,000 Common Stock

Also insider at

STOK

Stoke Therapeutics, Inc. Healthcare

RNA

Avidity Biosciences, Inc. Healthcare

Director

EMM

Edward M. Md Kaye

Director

South San Francisco, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CYTK shares.

Notify only if

Value

Insider Trading

Get notified when an Cytokinetics Inc insider buys or sells CYTK shares.

Notify only if

Operation

Value

Type

News

Receive news related to CYTOKINETICS INC

Track Activities on CYTK

Account